Cubist Systematic Strategies, LLC Keros Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $11,146 - $16,871	411 New	411 $16,000
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $159,295 - $228,026	3,844 Added 86.15%	8,306 $354,000
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $164,388 - $215,725	4,167 Added 1412.54%	4,462 $214,000
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $668,617 - $964,926	-24,051 Reduced 98.79%	295 $11,000
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $633,726 - $1.63 Million	24,346 New	24,346 $673,000
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $9,013 - $12,703	-214 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $175,808 - $299,230	-4,758 Reduced 95.7%	214 $13,000
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $145,530 - $217,326	4,972 New	4,972 $197,000
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $4,240 - $7,011	-100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$54.0 - $75.28 $5,400 - $7,528	-100 Reduced 50.0%	100 $6,000
Q4 2020 Feb 16, 2021	SELL	$36.0 - $82.74 $25,452 - $58,497	-707 Reduced 77.95%	200 $14,000
Q3 2020 Nov 16, 2020	BUY	$27.04 - $62.21 $243 - $559	9 Added 1.0%	907 $35,000
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $18,031 - $36,270	898 New	898 $34,000

157

27.1M

28.7K

1.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.45B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.